Drug safety
Carolina Infusion recalls 16 compounded medicines over sterility concerns
The FDA lists an ongoing nationwide recall of 16 Carolina Infusion compounded medicines over sterility assurance concerns tied to processing equipment.
FDA records list an ongoing recall of 16 compounded medicines from Carolina Infusion because of a lack of assurance of sterility related to processing equipment used in the products. The FDA classified the recall as Class II.
The products were distributed nationwide, and the recall started on 2026-09-10, according to the records, which report it on 2026-10-14. The FDA records identify the products as packaged in single-use dosage syringes, with the total volume dispensed based on each patient's prescription.
